The interplay between host cells and the human pathogen Trypanosoma cruzi: Role of toll-like receptors

The protozoan parasite Trypanosoma cruzi is the etiologic agent of Chagas disease, a neglected infectious disease that is becoming a world health concern. This obligate intracellular parasite employs a diversity of molecules and strategies to successfully invade a wide variety of mammalian cells and modulate host immune responses, which are essential features for completion of its life cycle in the host. The major plasma membrane antigens of T. cruzi infective trypomastigote forms are glycosylphosphatidylinositol (tGPI)-anchored mucin-like glycoproteins. Although previous studies demonstrated that the proinflammatory responses induced by tGPIs are mediated by Toll-like receptor (TLR) 2, the involvement of other TLRs and coreceptors has not been investigated yet. The focus of the first part of this dissertation was to investigate the molecular events involved in the interaction between T. cruzi and host cells and particularly, the upstream molecules implicated in tGPIs recognition by the innate immune system and the influence of the tGPI structural features on the biological activity and receptor/coreceptor requirement. To overcome the limitations related to heterogeneity and quantity of native GPI anchors, chemically synthesized tGPIs (stGPIs) were used. The stGPIs were preferentially recognized by the TLR2 and TLR6 heterodimer while co-expression of CD14 and CD36 accessory molecules induced a significant enhancement in cellular responses as assessed by NF-κB activation and IL-8 production. Further insights into the influence of the tGPI structural features on the biological activity and receptor/coreceptor requirement were also revealed. Intriguingly, in contrast to the well established role of TLR2 as one of the primary sensor of the innate immune defense against pathogens, activation of host cell TLR2 signaling by trypomastigote-released, GPI-containing vesicles was shown to facilitate T. cruzi invasion. This unanticipated role of TLR2 in host cell invasion by T. cruzi was further investigated. Clearly, TLR2-specific ligands significantly increased parasite infection in distinct cell types. In line with these findings, silencing of TLR2 by RNA interference significantly decreased infection. Moreover, the participation of host cell actin and intracellular calcium in TLR2-mediated invasion was assessed. Taken together, these results suggest that activation of host cell TLR2 by T. cruzi molecules may play a dual, paradoxical role during the infection by stimulating microbicidal responses and increasing the parasite infectivity. It also begins to reveal previously unrecognized mechanisms of host cell signaling subversion that may be exploited by other intracellular pathogens. In the second part of this research, a novel and improved approach to study in vitro models of host cell-parasite interaction and more specifically, T. cruzi infection, was developed. Conventional manual counting of parasite infection rate is extremely time-consuming and subjective. Hence, an approach based on high-content imaging and automated analysis in a multiwell plate format was developed to generate multiparametric data on a cell-by-cell basis which was further explored to precisely and quickly determine several parameters associated to in vitro infection of host cells. Statistical analysis confirmed that there was substantial agreement between the data acquired manually and by applying the automated analysis. Moreover, to further assess the applicability of this novel methodology, the effects of specific compounds on T. cruzi intracellular proliferation were evaluated. The results not only demonstrated the potential of the tested compounds as anti-T. cruzi agents, but also confirmed the effectiveness and uniqueness of high-content imaging in the determination of cytotoxic effects of the tested compounds as well as changes in T. cruzi infection rates and intracellular proliferation in a single experiment. Notably, this novel automated method may contribute to accelerate the discovery of potential drugs as well as the elucidation of molecular events related to the interaction between host cell and human intracellular pathogens

Lysophosphatidylcholine Triggers TLR2- and TLR4- Mediated Signaling Pathways but Counteracts LPSInduced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK Phosphorylation

Made available in DSpace on 2015-09-28T13:02:39Z (GMT). No. of bitstreams: 2 license.txt: 1914 bytes, checksum: 7d48279ffeed55da8dfe2f8e81f3b81f (MD5) igor_almeida_etal_IOC_2013.pdf: 680569 bytes, checksum: 68dcc939113bc5eb10c5deee819a7ff8 (MD5) Previous issue date: 2013Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Bioquímica Médica. Programa de Biologia Molecular e Biotecnologia. Instituto Nacional de Ciência e Tecnologia em Entomologia Molecular- INCT-EM. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Bioquímica Médica. Programa de Biologia Molecular e Biotecnologia. Instituto Nacional de Ciência e Tecnologia em Entomologia Molecular- INCT-EM. Rio de Janeiro, RJ, Brasil.University of Texas at El Paso. Department of Biological Sciences. The Border Biomedical Research Center. El Paso, Texas, USA.University of Texas at El Paso. Department of Biological Sciences. The Border Biomedical Research Center. El Paso, Texas, USA / Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Departamento de Biologia Celular e Molecular Patogênicos. Ribeirão Preto, SP, Brasil.University of Texas at El Paso. Department of Biological Sciences. The Border Biomedical Research Center. El Paso, Texas, USA.University of Texas at El Paso. Department of Biological Sciences. The Border Biomedical Research Center. El Paso, Texas, USA / Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Departamento de Biologia Celular e Molecular Patogênicos. Ribeirão Preto, SP, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Biofísica Carlos Chagas Filho. Laboratório de Parasitologia Molecular. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Bioquímica Médica. Programa de Biologia Molecular e Biotecnologia. Instituto Nacional de Ciência e Tecnologia em Entomologia Molecular- INCT-EM. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Bioquímica Médica. Programa de Biologia Molecular e Biotecnologia. Instituto Nacional de Ciência e Tecnologia em Entomologia Molecular- INCT-EM. Rio de Janeiro, RJ, Brasil.Background: Lysophosphatidylcholine (LPC) is the main phospholipid component of oxidized low-density lipoprotein (oxLDL) and is usually noted as a marker of several human diseases, such as atherosclerosis, cancer and diabetes. Some studies suggest that oxLDL modulates Toll-like receptor (TLR) signaling. However, effector molecules that are present in oxLDL particles and can trigger TLR signaling are not yet clear. LPC was previously described as an attenuator of sepsis and as an immune suppressor. In the present study, we have evaluated the role of LPC as a dual modulator of the TLR-mediated signaling pathway. Methodology/Principal Findings: HEK 293A cells were transfected with TLR expression constructs and stimulated with LPC molecules with different fatty acid chain lengths and saturation levels. All LPC molecules activated both TLR4 and TLR2-1 signaling, as evaluated by NF-қB activation and IL-8 production. These data were confirmed by Western blot analysis of NF-қB translocation in isolated nuclei of peritoneal murine macrophages. However, LPC counteracted the TLR4 signaling induced by LPS. In this case, NF-қB translocation, nitric oxide (NO) synthesis and the expression of inducible nitric oxide synthase (iNOS) were blocked. Moreover, LPC activated the MAP Kinases p38 and JNK, but not ERK, in murine macrophages. Interestingly, LPC blocked LPS-induced ERK activation in peritoneal macrophages but not in TLR-transfected cells. Conclusions/Significance: The above results indicate that LPC is a dual-activity ligand molecule. It is able to trigger a classical proinflammatory phenotype by activating TLR4- and TLR2-1-mediated signaling. However, in the presence of classical TLR ligands, LPC counteracts some of the TLR-mediated intracellular responses, ultimately inducing an anti-inflammatory phenotype; LPC may thus play a role in the regulation of cell immune responses and disease progression

LPC triggers IL-8 production through either TLR4- or TLR2/1-dependent signaling pathways.

<p>HEK 293A cells were transfected and stimulated as described on Figure 1. After 20 hours of incubation, IL-8 production was measured by the ELISA assay. Data is the mean ± S.E. of two different experiments. ** P < 0.01, *** P < 0.001 (One way ANOVA, Parameter, Bonferroni’s Multiple Comparison Test).</p

LPC triggers NF-қB activation through either TLR4- or TLR2/1-dependent signaling pathways.

<p>HEK 293A cells were transfected in three different groups. Groups A and B received expression constructs for TLR4 (<b>A</b>) or TLR2 and TLR1 (<b>B</b>). Both also received MD-2, CD14, and CD36 constructs and the ELAM-1-firefly luciferase and β-actin-<i>Renilla</i> luciferase reporter plasmids. The third group (<b>C</b>) received only the empty vector pDisplay and the luciferase reporter plasmids. Groups A and B were separately stimulated with 0.1, 1, 10, 100 and 200 µM of different types of LPC (Sigma; C14:0, C16:0, C18:0, and C18:1), 100 ng/mL of LPS and 1 nM of Pam3CSK4 (P3C). Group C was stimulated with LPS, Pam3Cys or 0.1, 1, 10 and 100 µM of LPC (C16:0). The agonists were diluted in DMEM medium with 10% bovine fetal serum. After 4 h of incubation, luciferase activity was measured and expressed as the ratio of NF-қB-dependent firefly luciferase activity to the control <i>Renilla</i> luciferase activity. Data is the mean ± S.E. of two different experiments. ** P < 0.01, *** P < 0.001 (One way ANOVA, Parameter, Bonferroni’s Multiple Comparison Test).</p

LPC inhibits NF-қB translocation, iNOS expression, and NO production in LPS-stimulated macrophages.

<p>Peritoneal macrophages from BALB/cmice were incubated in the absence or presence of 1 µg/mL LPS and different concentrations of LPC (Sigma) at 37 °C in a 5% CO₂ atmosphere. After 1 h of incubation, NF-қB translocation (<b>A</b>) was assayed by Western blot analysis. After 24 hours, NO production (<b>B</b>) was assayed by measuring the amount of nitrite in the culture supernatant using the Griess reagent, and iNOS expression (<b>C</b>) was determined by Western blot analysis followed by densitometry (lower panel). Data is the mean ± S.D. of three different experiments. * P < 0.05, ** P < 0.01, *** P < 0.001 (One way ANOVA, Parameter, Bonferroni’s Multiple Comparison Test).</p

LPC activates JNK and p38, but not ERK, in macrophages.

<p>Peritoneal macrophages from BALB/c mice were incubated in the absence or presence of different concentrations of LPC mix (Sigma) for 20 min at 37 °C in a 5% CO₂ atmosphere, and the cytoplasm content was homogenized and assayed as follows. The Phospho-MAPK array was used for analysis of enzymatic activation (<b>A</b>). The reaction was visualized with the enhanced chemiluminescent system and subjected to densitometric analysis (***, p< 0.001, ANOVA). Protein levels of the phosphorylated MAPKs JNK (<b>B</b>), p38 (<b>C</b>) and ERK (<b>D</b>) were determined by Western blot. Data is the mean ± S.E. of two different experiments.</p

LPC inhibits LPS-induced ERK activation.

<p>Peritoneal macrophages from BALB/c mice were incubated in the absence or presence of 1 µg/mL LPS or in the presence or absence of the indicated concentrations of LPC (Sigma) at 37 °C in a 5% CO₂ atmosphere (<b>A</b>, <b>D</b>, <b>E</b>). In parallel HEK 293A cells with TLR constructs as indicated (<b>B</b>, <b>C</b>). Each group received expression constructs for TLR4 (<b>B</b>) or both TLR2 and TLR1 (<b>C</b>), as well as MD-2, CD14 and CD36 plasmids. The cells were then incubated in the absence or presence of 100 ng/mL LPS or 1 nM Pam3CSK4 (P3C) and 10 or 100 µM of LPC, for 40 min at 37 °C in a 5% CO₂ atmosphere. After incubation either macrophages or HEK cells were homogenized, the protein levels was determined and samples evaluated by Western blot with the use of antibodies against p-ERK (<b>A</b>, <b>B</b>, <b>C</b>), p-JNK (<b>D</b>) and p-P38 (<b>E</b>). Loading controls were run with the use of antibodies raised towards actin. Experiments were performed at least two times with different animals and samples.</p